Abstract:Background:Defects in intestinal epithelial cells have been observed in Crohn's disease (CD) and are proposed to contribute to its pathogenesis and chronic nature. An unanswered question is whether these defects would continue to be observed once the epithelial cells are removed from their environment. We addressed this question using human epithelial spheroid culture, where primary intestinal epithelial cell lines are established from biopsy tissue, and a CD-associated epithelial gene signature that we previously observed in ∼75% of CD ileal resection tissue specimens. We also took the opportunity to examine inter-individual variation in spheroid lines generated from different patients and cultured in different conditions. Methods:We selected 38 ileal spheroid lines (19 CD and 19 controls without IBD) generated from tissue regions without active disease by endoscopic analysis. Spheroid lines were grown as enriched for stem cells or differentiated to enterocytes or wound-associated epithelial cells using distinct media. RNA was isolated from the cultured cells and biopsy tissue collected from the same patients at the same time for transcriptional analysis with a custom-designed Fluidigm assay for the CD-associated epithelial gene signature or Agilent microarrays. Morphological assessment was performed with ImageJ. Results:The CD-associated gene signature was observed in 50% of the CD biopsy samples, but was not maintained in cultured spheroids from the same patients. Thus, a persistent factor in the in vivo environment is likely the biological basis of this defect. Unsupervised hierarchical clustering of the microarray data showed a large transcriptional shift in the differentiated enterocytes and wound-associated epithelial (WAE) cell spheroids as compared to stem cell-enriched spheroids. Inter-individual variation was not obvious in stem cell samples, which nearly all clustered together. In contrast, the WAE cell samples formed multiple distinct clusters, suggesting that inter-individual variation is present in this growth condition. We previously observed that mouse intestinal spheroids exhibited a robust increase in area in the WAE cell medium. There was a similar response in human ileal spheroids, with a 1.9-fold average increase in spheroid area in WAE cell compared to stem cell media. This response was highly variable, ranging from no change to a 3-fold area increase in cell lines generated from different patients. Neither the transcriptional nor morphological phenotypes were dependent on patient diagnosis. Conclusions:We have examined a large number of intestinal spheroid lines and demonstrated that some epithelial phenotypes persist in culture whereas others do not. Inter-individual variation was evident in human spheroid lines generated from different patients in certain culture conditions. Thus, human spheroid lines are a very promising tool for understanding the basis of epithelial defects in Crohn's. Moreover, these results show that researchers will need to take care when selecting human intestinal spheroid lines for use in their studies.

New Year Message from the President

Role of microRNAs in cognitive decline related to COVID‐19 (Review)

Neurovascular coupling impairment as a mechanism for cognitive deficits in COVID-19

Comparison of Algorithms Controlling Concurrent Access to a Database: A Combinatorial Approach

O-013 Defining the Basis of Epithelial Defects in Crohn's Using Intestinal Spheroid Culture

Clinical and CSF single-cell profiling of post-COVID-19 cognitive impairment

Neuropsychological, plasma marker, and functional connectivity changes in Alzheimer's disease patients infected with COVID-19

Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment

Neuropsychological, Plasma Marker, and Functional Connectivity Changes in Alzheimer’s Disease Patients Infected with COVID-19

Neurological Complications of COVID-19: Unraveling the Pathophysiological Underpinnings and Therapeutic Implications

Social and Individual Commitment

Neuroinflammation in Post COVID‐19 Sequelae: Neuroinvasion and Neuroimmune Crosstalk

An overview of prognostic value of neurologic and cardiac biomarkers in patients with COVID-19 sequelae

Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19

Brain Pathology in COVID-19: Clinical Manifestations and Potential Mechanisms

Blood brain barrier disruption and glutamatergic excitotoxicity in post-acute sequelae of SARS COV-2 infection cognitive impairment: potential biomarkers and a window into pathogenesis

Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia

Long COVID and its association with neurodegenerative diseases: pathogenesis, neuroimaging, and treatment

Dysregulation of brain and choroid plexus cell types in severe COVID-19

Interstitial inflammation and scarring: messages from the proximal tubular cell.

Multi-Data Integration Towards a Global Understanding of the Neurological Impact of Human Brain Severe Acute Respiratory Syndrome Coronavirus 2 Infection